Precision Optics to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
Rhea-AI Summary
Precision Optics (Nasdaq:POCI) will present at the Planet MicroCap Las Vegas 2026 Investor Conference on Wednesday, June 17, 2026, at 11:00 a.m. Pacific time at the Bellagio Resort & Hotel in Las Vegas.
The presentation will be available via live webcast, and management will also hold in-person 1x1 investor meetings on June 17-18 for registered conference attendees.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
POCI’s modest 0.53% gain on very low volume contrasts with mixed peers: some like NXGL appear in momentum scanners with intraday gains, while others show declines, pointing to stock-specific rather than sector-driven dynamics.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| May 18 | Investor conference | Neutral | -1.6% | Announcement of participation in Lytham Partners Spring 2026 investor conference. |
| May 13 | Earnings results | Positive | +3.9% | Record Q3 FY2026 revenue, improved margins, narrowed net loss, and raised guidance. |
| May 06 | Earnings call scheduling | Neutral | +0.8% | Scheduling of Q3 FY2026 earnings release and conference call details. |
| May 05 | Follow-on order | Positive | +8.8% | Receipt of approximately $3.5 million follow-on production order for ophthalmic program. |
| Mar 27 | Equity offering | Negative | -0.5% | Pricing of upsized public offering of 2,777,777 shares at $3.60 per share. |
Recent news, especially positive operational and financial updates, has generally seen aligned price reactions, while routine conference announcements have produced modest moves.
Over the past few months, Precision Optics reported record Q3 FY2026 revenue and raised full-year guidance, announced a $3.5 million follow-on ophthalmic order, and completed an upsized $10 million public offering. It also scheduled and held multiple investor-facing events and conferences. Today’s Planet MicroCap conference participation continues this pattern of active investor outreach following improved fundamentals and fresh growth orders.
Market Pulse Summary
This announcement highlights continued investor-relations activity, with a Planet MicroCap Las Vegas 2026 presentation on June 17, 2026 and 1x1 meetings over June 17–18. It follows record Q3 FY2026 revenue, a $3.5 million follow-on ophthalmic order, and a recent equity raise that strengthened the balance sheet. Investors may watch for how management frames growth opportunities, capital deployment after the offering, and progress on newly scaled single-use endoscopy programs.
AI-generated analysis. Not financial advice.
LITTLETON, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it will be presenting at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub on Wednesday, June 17, 2026, at 11:00 a.m. Pacific time at the Bellagio Resort & Hotel.
To access the live webcast, please use the following information:
Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub
Date: Wednesday, June 17, 2026
Time: 11:00 a.m. Pacific time
Webcast: https://event.summitcast.com/view/bpjo3VVjZ25pp6SXpUua92/Prr9Qp5xjN9cMPciG4rsx3
Management also will be conducting investor meetings at the conference on June 17-18. If you would like to schedule a 1x1 investor meeting with Precision Optics, and to attend the Planet MicroCap Las Vegas 2026 investor conference, please make sure you are registered here: REGISTER. Meetings will be scheduled and conducted in person at the conference venue: Bellagio Resort & Hotel in Las Vegas, NV. The Planet MicroCap Las Vegas 2026 investor conference website is available here: HOME PAGE.
About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.
About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.
Company Contact:
PRECISION OPTICS CORPORATION
550 King Street, Building A, Suite 100
Littleton, MA 01460
Telephone: 978-630-1800
Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com
